Skip to content
← Back to this collection

PUBLICATIONS · 26668346

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2016 Feb 10
First author
Hong TS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hong TS
      type
      Author
    2. name
      Wo JY
      type
      Author
    3. name
      Yeap BY
      type
      Author
    4. name
      Ben-Josef E
      type
      Author
    5. name
      McDonnell EI
      type
      Author
    6. name
      Blaszkowsky LS
      type
      Author
    7. name
      Kwak EL
      type
      Author
    8. name
      Allen JN
      type
      Author
    9. name
      Clark JW
      type
      Author
    10. name
      Goyal L
      type
      Author
    11. name
      Murphy JE
      type
      Author
    12. name
      Javle MM
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hong TS
      type
      Author
    2. name
      Wo JY
      type
      Author
    3. name
      Yeap BY
      type
      Author
    4. name
      Ben-Josef E
      type
      Author
    5. name
      McDonnell EI
      type
      Author
    6. name
      Blaszkowsky LS
      type
      Author
    7. name
      Kwak EL
      type
      Author
    8. name
      Allen JN
      type
      Author
    9. name
      Clark JW
      type
      Author
    10. name
      Goyal L
      type
      Author
    11. name
      Murphy JE
      type
      Author
    12. name
      Javle MM
      type
      Author
    bibliography ids
    1. nci-bib-86ca7851dcf461e997077cce
    book metadata
    content sha256
    13f07e10e105c6ef930a1f3a1d912a68c4b8e6af9a7565810635011a36610ef6
    document type
    citation
    dois
    1. 10.1200/JCO.2015.64.2710
    electronic publication date
    display
    2015 Dec 14
    precision
    day
    year
    2015
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:26668346
    immutable id
    pubmed:26668346@13f07e10e105c6ef930a1f3a1d912a68c4b8e6af9a7565810635011a36610ef6
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    5
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    460-8
    volume
    34
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      26668346
      provenance
      batch id
      948d34b0dea86780a31d
      provider
      NCBI PubMed ESummary
      record sha256
      2e9d8f80cfafe89c415148387dde65d80bd6dadce84dd8f0a14d45eddce5ef36
      response sha256
      11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
      retrieved at
      2026-09-09T23:47:15.495091+00:00
      publication date
      display
      2016 Feb 10
      precision
      day
      year
      2016
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/26668346/
      title
      Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

      Preserved source evidence · Not medical advice